LATISSE^® at Discerning Eye

LATISSE^® is the first and only FDA-approved treatment that grows lashes longer, fuller and darker. And it’s the only lash growth product of its kind available by prescription.

The LATISSE^® Exam

Dr. Dan Wolfe offers LATISSE^® exams, which include an initial evaluation to determine if you are a candidate. The exam also includes a free LATISSE^® 30 day trial kit, your LATISSE^® prescription, and follow-up visit. There is a $50 fee for the exam, which does not include an eye exam for glasses or contacts.

Schedule your appointment today to start growing thicker, longer lashes!

Grow Longer, Fuller, and Darker Lashes

LATISSE^® solution is a once-nightly treatment you apply topically to the base of your upper eyelashes, as instructed by your doctor. Then, gradually, the results come in. You may start to see more length in as little as 4 weeks and you should achieve full growth in 16 weeks. It’s not an illusion of growth. It's real lash growth.

Joni Schrup, the owner of Discerning Eye, has been using LATISSE^® for over 6 months now and the results are fantastic! Stop in to see her longer, thicker lashes for yourself and talk to Joni about her LATISSE^® experience.

Before & After Photos #1

Before & After Photos #2

How It Works

LATISSE^® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE^® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.

The History

LATISSE^® was created by Allergan, a pharmaceutical leader with 60 years of eye care expertise. In 2001, Allergan developed a medicated eye drop to treat elevated intraocular pressure. Many patients using this medication also began to grow longer, fuller and darker lashes as a side effect. This led Allergan to study the medication's active ingredient, bimatoprost, specifically for growing lashes. After a clinical trial, LATISSE^® was approved by the FDA in December of 2008.